Key result
PCI shows similar 7-year major cardiovascular events rates compared to CABG in left main disease.
Why the study?
Decision-making factors and long-term clinical outcomes between PCI and CABG in left main disease are not well defined in the real world.
Does percutaneous coronary intervention (PCI) with drug-eluting stents result in comparable 7-year major adverse cardiovascular events compared to coronary artery bypass graft (CABG) surgery in real-world patients with left main coronary artery disease?
Cohort (n=230)
No
Does percutaneous coronary intervention (PCI) with drug-eluting stents result in comparable 7-year major adverse cardiovascular events compared to coronary artery bypass graft (CABG) surgery in real-world patients with left main coronary artery disease?
In real-world practice, clinician and patient selection of PCI versus CABG based on clinical risk (EuroSCORE II) and anatomical complexity (SYNTAX score, isolated LM disease) yields comparable 7-year MACE rates and a trend toward fewer hard clinical endpoints with PCI.
Answers are grounded in this paper and cite their sources.
Comparable 7-year MACE with PCI or CABG in selected left main patients; supports risk-based decisions but leaves open randomized confirmation.
Background: The decision-making factors and long-term clinical outcomes between PCI and CABG in left main (LM) disease are still not well defined in the real world. Methods: We evaluated consecutive patients (n = 230) with LM disease either treated by PCI (n = 118) or CABG (n = 112). The primary endpoint was major adverse cardiovascular events (MACE), defined as a composite of cardiac death, spontaneous myocardial infarction (MI), stroke, and target vessel revascularization (TVR) for 7 years. Results: In the multivariate-adjusted analysis, the presence of intermediate EuroSCORE II and high SYNTAX scores predisposed to CABG. Isolated LM disease was associated with receiving PCI. The PCI group had a similar rate of MACE (HRadj 0.97, 95% CI [0.48–1.94], p = 0.92) and a lower tendency of hard MACE (HRadj 0.49, 95% CI [0.22–1.07], p = 0.07) compared to the CABG group, mainly due to the balance between a higher rate of TVR (HRadj 9.71, p = 0.02) and a lower rate of stroke (HRadj 0.22, p = 0.09) with the PCI group than in the CABG group. Conclusions: The decision making of treatment strategy was made based on clinical and angiographic factors. The selected patients who received PCI showed similar MACE and trend of a lower rate of composite hard endpoints despite multivariate adjustment.
No takes yet. Share an insight, caveat, or question.
Jang et al. (2022) conducted a cohort in Left main coronary artery disease (n=230). Percutaneous coronary intervention (PCI) with drug-eluting stents vs. Coronary artery bypass graft (CABG) surgery was evaluated on Major adverse cardiovascular events (MACE), defined as a composite of cardiac death, spontaneous myocardial infarction (MI), stroke, and target vessel revascularization (TVR) for 7 years (HRadj 0.97, 95% CI 0.48–1.94, p=0.92). Percutaneous coronary intervention resulted in a similar 7-year rate of major adverse cardiovascular events compared to CABG in left main disease.
Synapse has enriched 10 related papers. Consider them for comparative context: